LightForce Deep Tissue Laser
Commercial- Indications
- Traumatic brain injury, Chronic pain, Musculoskeletal disorders
Company intelligence / Profile preview
LiteCure has commercialized FDA-cleared Class IV therapeutic lasers used widely in human medicine, sports medicine, veterinary clinics, and equine care. Its devices are supported by ISO-certified manufacturing standards. The company also participates in clinical research—most notably a Phase II study of transcranial photobiomodulation for Alzheimer’s disease—and has entered strategic partnerships to enable light-based targeted cancer therapies.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LiteCure.